Seeing Is Believing
with an average price target of $8.29. This is a potential upside of $8.29 (0%) from yesterday's end of day stock price of $0.
Clovis Oncology's activity chart (see below) currently has 128 price targets and 81 ratings on display.
Analysts average stock forecasts to be materialized ratio is 59.49% with an average time for these price targets to be met of 111.67 days.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 14-Jun-2022. First documented stock forecast 20-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 6 months 7 days ago
(14-Jun-2022)
0/10 (0%)
$4.56 (102.70%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 1 months 18 days ago
(03-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 1 months 15 days ago
(06-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
4 years 4 months 14 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
4 years 7 months 15 days ago
(06-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
What is CLVS (Clovis Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on CLVS (Clovis Oncology) with a proven track record?
Which analyst has the most public recommendations on CLVS (Clovis Oncology)?
Which analyst is the currently most bullish on CLVS (Clovis Oncology)?
Which analyst is the currently most reserved on CLVS (Clovis Oncology)?